N@N

ERES, CVGW, HK, CBST, CSTR, CRY Are Seasonally Ripe To Go Down In the Next Five Weeks

^{Published on 2010-11-08 09:45:13, Last Modified on 2010-12-22 19:23:42 - WOPRAI}
 

November 8, 2010 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of ERESEARCH TECHNOLOGY INC (NASDAQ:ERES), CALAVO GROWERS INC (NASDAQ:CVGW), PETROHAWK ENERGY CORP (NYSE:HK), CUBIST PHARMACEUTICALS INC (NASDAQ:CBST), COINSTAR INC (NASDAQ:CSTR), CRYOLIFE INC (NYSE:CRY) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at: http://www.squeezetrigger.com/services/strat/mh.php

The following stocks are expected to go Down:

     Symbol     Company                         Expected Return     Odds                    By The Following Date
     ERES       ERESEARCH TECHNOLOGY INC        -6.470 %            61.54% (8 of 13)        Thursday, November 11th 2010
     CVGW       CALAVO GROWERS INC              -6.460 %            75.00% (6 of 8)         Thursday, December 2nd 2010
     HK         PETROHAWK ENERGY CORP           -6.360 %            72.73% (8 of 11)        Tuesday, November 23rd 2010
     CBST       CUBIST PHARMACEUTICALS INC      -6.250 %            57.14% (8 of 14)        Wednesday, November 17th 2010
     CSTR       COINSTAR INC                    -5.670 %            61.54% (8 of 13)        Thursday, November 18th 2010
     CRY        CRYOLIFE INC                    -5.260 %            70.59% (12 of 17)       Monday, November 22nd 2010

ERESEARCH TECHNOLOGY INC (NASDAQ:ERES) - eResearchTechnology, Inc., together with its subsidiaries, provides technology and service solutions that enable the pharmaceutical, biotechnology, and medical device industries to collect, interpret, and distribute cardiac safety and clinical data. The companys cardiac safety products and service solutions include EXPERT, which provides workflow enabled cardiac safety data collection, interpretation, and distribution of electrocardiographic (ECG) data and images, and enables analysis and cardiologist interpretation of ECGs performed on research subjects. It also provides centralized ECG testing services, which include digital ECG services; continuous digital 12-lead ECG recording; Holter recording, a continuous recording of the hearts rhythm on a flash card; paper ECG services; FDA XML ECG services that provide clients electronic versions of ECG processed by EXPERT; MyStudy Portal, a hosted solution that provides sponsors and investigator sites the ability to order supplies, get real time reports, and respond to queries through a secure Web portal; and cardiac safety equipment. In addition, the company offers cardiac safety consulting; ePRO, an electronic patient reported outcome service that allows subjects to report data for a clinical trial; and project assurance services comprising study initiation, project management, site qualification, configuration, technology and regulatory review, research dashboards and electronic reporting, data management, uniform standards and standard operating procedures, migration services, onsite research and technology advisory services, support services, including online and help desk support, and software maintenance. It markets and sells service solutions through global direct sales, sales support, and professional services organizations with principal operations in the United States and the United Kingdom. The company was founded in 1977 and is headquartered in Philadelphia, Pennsylvania.

CALAVO GROWERS INC (NASDAQ:CVGW) - Calavo Growers, Inc. engages in the procurement and marketing of avocados and other perishable commodities, as well as in the preparation and distribution of processed avocado products worldwide. It operates through two segments, Fresh Products and Processed Products. The Fresh Products segment engages in the procurement of avocados grown in Chile, Mexico, and Peru, as well as various other commodities, including tomatoes, papayas, mushrooms, and pineapples. The Processed Products segment processes avocados into various guacamole products, as well as distributes the processed products comprising frozen and cold pasteurized fresh guacamole products. The company sells its products to food distributors, produce wholesalers, supermarkets, and restaurants. Calavo Growers, Inc. was founded in 1924 and is headquartered in Santa Paula, California.

PETROHAWK ENERGY CORP (NYSE:HK) - Petrohawk Energy Corporation engages in the exploration, development, and production of oil and natural gas properties in the United States. The company holds interests in various properties located in North Louisiana, Arkansas, South Texas, East Texas, and Oklahoma. As of December 31, 2009, it had total proved oil and natural gas reserves of approximately 2,750 billion cubic feet of natural gas equivalents. The company was founded in 1997 and is based in Houston, Texas.

CUBIST PHARMACEUTICALS INC (NASDAQ:CBST) - Cubist Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the research, development, and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment. The company markets CUBICIN (daptomycin for injection), the first antibiotic in a new class of anti-infectives called lipopeptides in the United States. It also promotes MERREM I.V. (meropenem for injection) in the U.S. under an agreement with AstraZeneca Pharmaceuticals, LP. The companys clinical product pipeline consists of ecallantide, a recombinant human protein being developed for the reduction of blood loss during cardiac surgery, for which Phase 2 data is under analysis; a Phase 2 program focused on the development of a novel cephalosporin to address certain serious infections caused by multi-drug resistant (MDR) Gram-negative organisms; a program for the treatment of CDAD (Clostridium difficile-associated diarrhea), which is entering Phase 2; and a Phase 1 program to address the unmet medical need for a treatment for serious infections caused by MDR Gram-negative pathogens. Cubist Pharmaceuticals is also working on various pre-clinical programs, including an anti-infective program for the treatment of respiratory syncytial virus (RSV) in children, therapies to treat various serious bacterial infections, and agents to treat acute pain. It has a collaboration agreement with Alnylam Pharmaceuticals, Inc. for developing Alnylams RNA interference to treat RSV. The company was founded in 1992 and is headquartered in Lexington, Massachusetts.

COINSTAR INC (NASDAQ:CSTR) - Coinstar, Inc. provides automated retail solutions primarily in the United States, Canada, Puerto Rico, the United Kingdom, Mexico, and Ireland. It owns and operates self-service coin-counting machines, which enable consumers convert their coins to cash, a gift card, or an e-certificate; and installs and operates DVD kiosks, which enable costumers to rent or purchase movies. The company also offers money transfer services. Coinstar offers its services at approximately 95,000 points of presence, including supermarkets, drug stores, mass merchants, financial institutions, convenience stores, restaurants, and money transfer agent locations. As of December 31, 2009, it owned and operated approximately 19,200 coin-counting machines and 22,400 DVD kiosks. The company was founded in 1991 and is headquartered in Bellevue, Washington.

CRYOLIFE INC (NYSE:CRY) - CryoLife, Inc. engages in the processing and distribution of implantable living human tissues for use in cardiac and vascular surgeries in the United States and Canada. Its CryoValve SG pulmonary heart valve, processed using CryoLife's proprietary SynerGraft technology, has FDA 510(k) clearance for the replacement of diseased, damaged, malformed, or malfunctioning native or prosthetic pulmonary valves. The companys CryoPatch SG pulmonary cardiac patch has FDA 510(k) clearance for the repair or reconstruction of the right ventricular outflow tract, a surgery commonly performed in children with congenital heart defects, such as tetralogy of Fallot, truncus arteriosus, and pulmonary atresia. CryoPatch SG is distributed in three anatomic configurations: pulmonary hemi-artery, pulmonary trunk, and pulmonary branch. CryoLifes BioGlue Surgical Adhesive is FDA approved as an adjunct to sutures and staples for use in adult patients in open surgical repair of vessels. BioGlue is also CE Marked in the European community and approved in Canada and Australia for use in soft tissue repair. The companys BioFoam Surgical Matrix is CE Marked in the European community for use as an adjunct in the sealing of abdominal parenchymal tissues when cessation of bleeding by ligature or other conventional methods is ineffective or impractical. BIOGLUE Aesthetic Medical Adhesive is CE marked in the European Community for periosteal fixation following endoscopic browplasty in reconstructive plastic surgery. CryoLife also distributes HemoStase, a hemostatic agent for use in cardiac and vascular surgery, as well as in various international markets for cardiac, vascular, and general surgery. The company distributes its products through field service representatives, cardiac specialists, direct field representatives, and independent distributors. CryoLife was founded in 1984 and is headquartered in Kennesaw, Georgia.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641